Developer of a disease-targeted senolytic compound designed to support healthier aging and tissue function. The company offers research and development of compounds aimed at identifying and eliminating senescent cells associated with various diseases, enabling clients to explore potential treatments that may improve cellular resilience, slow tissue degeneration, and support overall health.